Usefulness of anti-phosphohistone H3 immunoreactivity to determine mitotic rate in gastrointestinal stromal tumors
Basic and Applied Pathology Aug 03, 2019
Kim A, Im DH, Kim K, et al. - Since it is not always easy to look for mitotic figures and count them correctly on hematoxylin and eosin-stained (H&E) slides, therefore, through a study, the researchers intended to assess the benefits of anti-phosphohistone H3 immunoreactivity in determining the mitotic rate in gastrointestinal stromal tumors. Among phopho-histone H3 (PHH3)-MI and mitotic count on H&E sections (H&E-MI), a strong association was discovered. Recurrence-free survival was related to the risk category by NIH consensus criteria, mucosal invasion, H&E-MI, Ki-67 expression, and PHH3-MI. However, none of the formerly mentioned factors was an independent prognostic factor. Therefore, PHH3 staining was primarily discovered to sustain grading by promoting mitotic counting and it might have a prognostic value in the gastrointestinal stromal tumors.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries